The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types.

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

Pancreatic cancer pill vaccine shows promising trial results, nearly doubling survival and prompting phase 2 studies, per AACR reports.

There is some promising news for pancreatic cancer research, as medical data show lasting results from the trial of a vaccine ...

Scientists could soon develop personalized cancer vaccines.

Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

Breakthrough mRNA technologies, strong U.S. leadership, and rising awareness of RSV risks fuel unprecedented market expansion.Austin, United States, April 27, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

An mRNA vaccine for avian influenza, developed by pharma company Moderna, has begun Phase 3 human trials. Building on the ...